Thus, combining DNA methylation analysis with p16 and Ki67 immunohistochemical staining may provide a biomarker phenotype to improve clinical guidance for women with CIN and prevent overtreatment of reversible lesions and potential obstetric complications. Here, MKI67 is linked to cervical squamous intraepithelial neoplasia.